SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets)

Antonio Secchi

Status: Completed

Conditions: Pancreatic Transplat; Pancreatic Islets Langerhans; Kidney Transplant

Treatments: Procedure: blood sample for seroepidemiological investigation

Study type: Observational

Funder types: Other

Identifiers

NCT04487197

COVID-SIERO TRAPIANTI

Details and patient eligibility

About

Evaluate SARS-CoV2 infection and the degree of immunity possibly developed in transplanted population using the Luciferase Immuno Precipitation System (LIPS) test.

Enrollment: 282 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria Cohort 1:

• Adult patients (age ≥ 18 years),
• Kidney or pancreas or pancreatic islets transplantation
• Transplanted patients (period: 01.01.2020 to 30.06.2020)
• Informed Consent signed

Inclusion Criteria Cohort 2:

• Adult patients (age ≥ 18 years),
• Kidney or pancreas or pancreatic islets transplantation
• transplanted patients in follow-up since 01.01.2020 or trasplanted patients after 30.06.2020.
• Informed Consent signed

Exclusion Criteria both Cohort (1&2):

Symptomatology such as fever> 37.5, and / or cough and / or respiratory distress and / or diarrhea / vomiting in 14 days prior to collection of blood sample

Trial design

282 participants in 2 patient groups

Cohort 1

Description:

* Adult patients (age ≥ 18 years), * kidney or pancreas or pancreatic islets transplantation * transplanted patients (period: 01.01.2020 to 30.06.2020)

Treatment:

Procedure: blood sample for seroepidemiological investigation

Cohort 2

Description:

* Adult patients (age ≥ 18 years), * kidney or pancreas or pancreatic islets transplantation * Transplanted patients in follow-up since 01.01.2020 or trasplanted patients after 30.06.2020.

Treatment:

Procedure: blood sample for seroepidemiological investigation